US EditionFDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures
The panel will weigh whether compounding pharmacies can make the drugs after FDA restrictions pushed demand into gray markets, officials said.
- On Wednesday, the Food and Drug Administration announced it will convene an outside panel of advisers in July to review whether compounding pharmacies can manufacture seven specific peptide injections.
- Health Secretary Robert F. Kennedy Jr. has repeatedly pledged to loosen restrictions on these unapproved therapies, which proponents market as aids for building muscle, healing injuries, or appearing younger.
- In 2023, federal regulators restricted 19 peptides, citing safety risks like cancer and organ damage, after an advisory panel determined they lacked sufficient human testing for safe compounding.
- On platforms like TikTok, overseas suppliers sell peptide varieties from China for as little as $5 a vial, a market the industry argues exists because of current U.S. regulatory restrictions.
- The upcoming panel will evaluate whether substances like BPC-157 and TB-500 should return to the list of routinely compounded drugs, despite ongoing regulatory concerns about their unproven safety.
65 Articles
65 Articles
FDA will consider easing restrictions on peptides as RFK Jr. calls himself a "big fan"
The FDA meeting announcement follows repeated pledges by Health Secretary Robert F. Kennedy Jr. to loosen regulations on peptides, which are often pitched as a quick way to build muscle, heal injuries or appear younger.
FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters
The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular among wellness influencers, fitness gurus and celebrities.
FDA will consider easing restrictions on peptides touted by RFK Jr., MAHA figures
The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen injections, a group of unapproved therapies that have become popular among wellness influencers, fitness gurus and celebrities.The meeting announcement Wednesday follows…
FDA weighs easing rules on unapproved peptides embraced by RFK Jr
WASHINGTON — The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular among wellness influencers, fitness gurus and celebrities.
Coverage Details
Bias Distribution
- 57% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
